GKOS
GLAUKOS Corp
NYSE · Healthcare · Medical - Devices · US
$242.48
+33.65%Margins
Gross margin
81.1%
EBITDA margin
-19.6%
EBIT margin
-9.2%
Net margin
-24.6%
FCF margin
5.2%
-23.7%
Return on equity
-17.3%
Return on assets
-7.7%
Return on invested capital
0.73x
Asset turnover
$47.7M
Cash from operations
$5.71
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026